Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. (Q34049618)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.
scientific article

    Statements

    Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. (English)
    0 references
    Jill C Rubinstein
    Anna C Pavlick
    Stephan Ariyan
    Elaine Cheng
    Harriet M Kluger
    Deepak Narayan
    Ruth Halaban

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit